Cross-species Study of Canine and Human Peripheral Nerve Sheath Tumors: Clinical and Molecular Perspectives
Landry, J. P.; Bhalla, A. D.; Landers, S. M.; Lazcano, R.; Parker, L. A.; Miller, T. M.; Niemi, N.; Lyu, H.; Lillemoe, H.; Keung, E. Z.; Scally, C. P.; Roland, C. L.; Hunt, K. K.; Slopis, J. M.; McCutcheon, I. E.; Boudreau, B.; Wilson-Robles, H.; Lazar, A. J.; Rai, K.; Wiener, D. J.; Davis, B. W.; Wustefeld-Janssens, B.; Torres, K. E.
Show abstract
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas. An obstacle to treating MPNSTs is a lack of effective systemic therapies. Although over 70% of human MPNSTs have lost or inactivated the epigenome regulator polycomb repressive complex 2 (PRC2), its activity and contribution to canine PNST progression remain unclear. This study compared canine peripheral nerve sheath tumors (PNSTs) and human MPNSTs across biological and clinical features, including PRC2 activity. Immunohistochemical analysis was performed for a human tissue microarray of 54 neurofibromas and 139 MPNSTs, and 63 canine PNSTs for H3K27me3, a repressive histone mark deposited by intact PRC2, and H3K27ac, which increases globally upon H3K27me3 loss. To understand the genomic alterations present in canine PNSTs, we analyzed tumor mutation burden, copy number alteration, and transcriptomes of eight canine PNST/normal pairs. The results suggested that H3K27me3 loss and associated gain of H3K27ac epigenetically drive human and canine tumors. These findings warrant further studies to evaluate whether these epigenetic deregulations alter similar gene signatures across species.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Blood and Tissue Biomarker Analysis in Dogs with Osteosarcoma Treated with Palliative Radiation and Intra-Tumoral Autologous Natural Killer Cell Transfer 95%
- PD-L1 expression in 522 selected sarcomas with subset analysis of recurrent or metastatic matched samples and association with tumour-infiltrating lymphocytes 94%
- Monitoring plasma nucleosome concentrations to measure of disease response and progression in dogs with hematopoietic malignancies. 93%
Similar papers in this journal
- Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer 93%
- Meta-Analysis of Adenoviral p53 Gene Therapy Clinical Trials in Recurrent Head and Neck Squamous Cell Carcinoma 92%
- Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies. 91%
Similar papers in this journal
- Canine oral melanoma genomic and transcriptomic study defines two molecular subgroups with different therapeutical targets 95%
- Capacity for compensatory cyclin D2 response confers trametinib resistance in canine mucosal melanoma 92%
- Development of a Single Molecule Counting Assay to Differentiate Chromophobe Renal Cancer and Oncocytoma in Clinics 92%
Similar papers in this journal
- Optical Genome Mapping Identifies a Novel Pediatric Embryonal Tumor Subtype with a ZNF532-NUTM1 Fusion 93%
- Oronasal mucosal melanoma is defined by two transcriptional subtypes in humans and dogs with implications for diagnosis and therapy 92%
- Hippo pathway effectors YAP1/TAZ induce a EWS-FLI1-opposing gene signature and associate with disease progression in Ewing Sarcoma 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.